GERD After Sleeve Gastrectomy

The main adverse effect is gastroesophageal reflux disease (GERD), with concern on the development of Barrett's esophagus and esophageal adenocarcinoma in the long term. However, the relationship between SG and GERD is complex. The aim of this study is to systematically evaluate all published data existing in the literature to evaluate the effect of sleeve gastrectomy on GERD, esophagitis, BE in order to clarify the long-term clinical sequelae of this procedure.

This systematic review was conducted in accordance with the guidelines for Preferred Reporting Items for Systematic Review and Meta-analyzes (PRISMA).

Published studies that contained outcome data for primary sleeve gastrectomy associated with the primary and secondary outcomes listed below were included.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Morbid Obesity Body Weight Deglutition Disorders Digestive System Diseases Esophageal Diseases Esophageal Motility Disorders GERD Gastroesophageal Reflux Gastrointestinal Diseases Nutrition Disorders Nutritional and Metabolic Diseases Obesity Obesity, Morbid Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Foggia

Foggia, 71122, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients underwent to sleeve gastrectomy with reflux symptoms

Exclusion criteria

Patients underwent to other bariatric procedures

Treatment and study plan

Primary outcomes

Gastroesophageal reflux disease after bariatric surgery

Time frame: from 2014 to 2018

Number of patients underwent sleeve gastrectomy with GERD

Sponsors and collaborators

Lead sponsor

University of Foggia

Other

Registry information

Official study title

The New Onset of GERD After Sleeve Gastrectomy: a Systematic Review

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Jan 5, 2022
Registry last updated: Jan 5, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed